Lung Cancer, Survivors (RELAX) (WF01213)
Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX)
The purpose of this research study is to compare the effects of music and different levels of device-guided breathing on anxiety and shortness of breath in lung cancer survivors.
Key Inclusion Criteria
For a patient to be eligible for participation in this study, all of the following criteria must apply.
- Histologic or cytologic diagnosis of primary non-small cell Stage 0-II lung cancer,
- 2- 24 months post-completion of surgery, radiation therapy and/or chemotherapy with no further planned treatment during the 8-week study
- Score of ≥8 on the anxiety subscale of the HADS1
- Eastern Cooperative Oncology Group performance status 0-2
- Hemoglobin ≥9.5
- Smoking status anticipated to be stable during the study
- Willing/able to attend brief introductory session and use assigned device for the assigned period of time (15 minutes once or twice per day), 5 days per week for 8 weeks.
- Age ≥18 years
Key Exclusion Criteria
A patient will not be eligible for participation in this study if any of the following criteria apply.
- Patient does not understand English
- Active lung infection
- Radiation pneumonitis currently being treated with oral steroids
- Unstable angina
- Pulmonary embolism in past six months
- Progressive cancer (must be considered no evidence of disease or stable)
- Active suicidal ideation with plan or intent
- Any change in psychotropic medications in past month
- Hearing loss that would preclude participating in interventions.
To learn more, visit ClinicalTrials.Gov
Patricia Griffin, MD
Wake Forest University Health Sciences